DRIO Stock Analysis: Buy, Sell, or Hold?
DRIO - DarioHealth Corp. Common Stock
$5.99
-0.35 (-5.52%)
▼
5d:
-16.22%
30d:
-20.66%
90d:
-20.13%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When DRIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DRIO is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: DRIO is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: DRIO is currently trading at $5.99, which is considered oversold relative to its 30-day fair value range of $6.92 to $7.93.
Technical Outlook: Technically, DRIO is in a strong downtrend. The price is currently testing key support at $6.97. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.50 (+208.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DRIO is in a strong downtrend. The price is currently testing key support at $6.97. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.50 (+208.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.92 -
$7.93
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 208.8% below Wall St target ($18.50)
- WARNING: Recommendation downgraded due to -16.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$6.92 -
$7.93
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.97
Resistance Level
$8.12
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.81
Wall Street Target
$18.50
(+208.8%)
Revenue Growth (YoY)
-17.3%
Profit Margin
-192.2%
Share & Embed Analysis
Last updated: June 24, 2026 3:44 AM ET
Data refreshes hourly during market hours. Next update: 4:44 AM
Data refreshes hourly during market hours. Next update: 4:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DRIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 51 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 53 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 56 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 57 HOLD |
